Methylation age as a correlate for allele burden, disease status, and clinical response in myeloproliferative neoplasm patients treated with vorinostat
Open Access
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 79, 26-34
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A phase II study of vorinostat (MK‐0683) in patients with polycythaemia vera and essential thrombocythaemiaBritish Journal of Haematology, 2013
- Self-Renewal of Single Mouse Hematopoietic Stem Cells Is Reduced by JAK2V617F Without Compromising Progenitor Cell ExpansionPLOS Biology, 2013
- Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasmsHaematologica, 2013
- JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes MyeloproliferationCancer Cell, 2011
- Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancerGenome Research, 2010
- JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatinNature, 2009
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLOS Medicine, 2006
- The clinical phenotype of wild‐type, heterozygous, and homozygous JAK2V617F in polycythemia veraCancer, 2005
- Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitorsLeukemia, 2005
- Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824Cancer Research, 2004